Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Gastric Cancer
Interventions
DRUG

Anlotinib

Anlotinib p.o. qd

DRUG

Placebo

Placebo p.o. qd

Trial Locations (38)

100142

RECRUITING

Beijing Cancer Hospital, Beijing

132000

RECRUITING

Jilin Cancer Hospital, Changchun

200032

NOT_YET_RECRUITING

Fudan University Zhongshan Hospital, Shanghai

200080

NOT_YET_RECRUITING

Shanghai General Hospital, Shanghai

213003

RECRUITING

The First People's Hospital of Changzhou, Changzhou

250117

RECRUITING

Shandong Tumor Hospital, Jinan

310016

RECRUITING

Sir Run Run Shaw Hospital School of Medical,Zhejiang University, Hangzhou

330006

RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

NOT_YET_RECRUITING

The Second Affiliated Hospital of Nanchang University, Nanchang

350001

RECRUITING

Union Hospital of Fujian Medical University, Fuzhou

400042

RECRUITING

Chongqing Daping Hospital, Chongqing

410008

NOT_YET_RECRUITING

Xiangya Hospital Central South University, Changsha

410013

NOT_YET_RECRUITING

The Third Xiangya Hospital Central South University, Changsha

421001

RECRUITING

The General Hospital of Nanhua University, Hengyang

430022

RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

430030

RECRUITING

Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

450052

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

530021

RECRUITING

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

730070

RECRUITING

Lanzhou General Hospital, Lanzhou

Unknown

RECRUITING

The First Affiliated Hospital, Anhui Medical University, Hefei

RECRUITING

The 307th Hospital of Chinese People's Liberation Army, Beijing

NOT_YET_RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Harbin medical university affiliated tumor hospita, Harbin

RECRUITING

Henan Province Tumor Hospital, Luoyan

RECRUITING

Hunan Province Tumor Hospital, Changsha

NOT_YET_RECRUITING

Jiangsu Cancer Hospital, Nanjing

RECRUITING

Jiangsu Province Hospital, Nanjing

RECRUITING

Nantong Cancer Hospital, Nantong

NOT_YET_RECRUITING

Jiangxi Cancer Hospital, Nanchang

RECRUITING

Liaoning Province Tumor Hospital, Shenyang

RECRUITING

Linyi City Tumor Hospita, Linyi

NOT_YET_RECRUITING

Cancer Hospital of Fudan University, Shanghai

RECRUITING

Tangdu Hospital of The fourth Military Medical University, Xian

NOT_YET_RECRUITING

Tianjin Medical University Cancer Hospital, Tianjin

RECRUITING

Tianjin Medical University General Hospital, Tianjin

RECRUITING

Yunnan Province Tumor Hospital, Kunming

050011

RECRUITING

Fourth Hospital of Hebei Medical University Tumor Hospital of Hebei Province, Shijiazhuang

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY